Home » Healthcare » Postoperative Pain Medication Market

Postoperative Pain Medication Market By End-Users (Hospitals and Clinics, Ambulatory Surgery Centers, Pain Management Centers) By Patient Profile (Adult Patients, Pediatric Patients, Geriatric Patients) – Growth, Share, Opportunities & Competitive Analysis, 2018 – 2028

Price: $4999

Published: | Report ID: 22011 | Report Format : PDF

Market Insights

  • The global demand for postoperative pain medication was valued at USD 32154.9 Million in 2022 and is expected to reach USD 50481.5 Million in 2030, growing at a CAGR of 5.80% between 2023 and 2030.
  • The opioid category maintained a dominant market share, and NSAIDs are predicted to grow at the quickest CAGR.
  • The oral category retains a dominant market share, while the intravenous sector holds the market’s second highest share.
  • Orthopedic surgery is a major player in the postoperative pain treatment sector. Abdominal procedures are another important component of the postoperative pain management market.
  • Ambulatory surgery centres are the fastest growing sector in the postoperative pain treatment industry, while hospitals and clinics are another segment with significant market demand.
  • Pediatric patients have the highest compound annual growth rate (CAGR), and geriatric patients are another important market segment among them.
  • North America held a 35% market share in 2022, and Asia-Pacific is predicted to grow at the fastest CAGR.
  • The expansion of ambulatory surgical centres increases the size of the postoperative pain market to drive market growth.
  • The unpleasant side effects of medication are hindering market growth.

Executive Summary

Market Definition

Postoperative pain management refers to the medical tactics and interventions used to relieve patients’ pain and discomfort following surgical procedures. It entails the administration of drugs, such as analgesics, to control pain and assure the patient’s comfort during the recovery phase. Non-pharmacological pain management approaches, such as physical therapy, relaxation techniques, and alternative therapies, may also be used to supplement the pain management plan. Postoperative pain management’s primary purpose is to offer effective pain relief, promote patient recovery, and improve overall outcomes following surgery.

Design Element 2

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

CTA Design Element 3

Market Overview

It is anticipated that between 2023 and 2030, the worldwide Postoperative Pain Medication Market will expand at a compound annual growth rate (CAGR) of 5.80%from USD 32154.9 million in 2022, the market is projected to be worth USD 50481.5 million by 2030.

The postoperative pain management industry is expected to expand significantly in the future years. Several factors are driving this expansion, including an increase in the number of surgical procedures performed globally. Furthermore, the rising prevalence of chronic conditions demanding surgery, as well as the growing elderly population, are driving market growth.

However, there are certain limitations to consider. The risk of side effects associated with pain drugs is one of the major concerns, which has led to an increasing preference for non-pharmacological pain management strategies. This shift in desire gives an opportunity for the development of novel pain management therapies with minimal adverse effects.

Overall, the market for postoperative pain management presents a great opportunity for companies to deliver novel pain management solutions. There is great potential for significant development and improvement in patient outcomes by addressing the limits of existing drugs and tapping into the desire for non-pharmacological treatments.

Segmentation by Medication Type

  • In 2022, the opioid category retained a commanding market share. This is due to the ingestion of opioids or opiates via numerous routes such as oral, transdermal, parenteral, neuraxial, and rectal. Morphine, paracetamol, hydromorphone (Dilaudid), and fentanyl are the most often used intravenous opioids for postoperative pain.
  • NSAIDs, are expected to expand at the fastest CAGR of 6.1% between 2022 and 2030. This is because nonsteroidal anti-inflammatory medications are used to manage postoperative pain. NSAIDs, such as Naproxen, are quite effective for postoperative pain control.

Segmentation by Role of Administration

  • In 2022, the oral category retained a commanding market share because oral administration is the most common means of treating acute or chronic pain, morphine, hydromorphone, paracetamol, hydrocodone, and oxycodone are commonly utilized.
  • The intravenous segment holds the second largest share in the market. Intravenous pain management involves the administration of pain medication directly into the bloodstream, providing quick and effective pain relief.

Segmentation by Surgical Procedure

  • One of the most dominant areas in the postoperative pain treatment industry is orthopedic surgery.
  • Another key component of the postoperative pain management market is abdominal procedures.

Segmentation by End-Users

  • Ambulatory surgery centres are the postoperative pain management market’s fastest expanding sector. This is because, when compared to hospitals and clinics, ambulatory surgery centres provide various advantages such as cost-effectiveness, convenience, and quicker recovery times.
  • Hospitals and clinics are another segment with considerable market demand. Hospitals and clinics play an important role in providing patients with comprehensive postoperative pain management services.

Segmentation by Patient Profile

  • The pediatric patients sector has the greatest compound annual growth rate (CAGR). This is due to increased awareness and focus on pediatric pain management, developments in pediatric surgical methods, and a rising demand for specialist pain management treatments for children having surgery.
  • The geriatric patients sector is another key market segment among them. As the population ages, so does the demand for specialized pain care for older persons having surgery.

Segmentation by Region

  • North America held a dominant market share of 35% in the year 2022.
  • Over the projected period 2022-2030, Asia-Pacific is expected to develop at the quickest CAGR
  • The rest of the world, including Latin America, the Middle East, and Africa, supplies the remaining demand for Postoperative Pain Medication.

In the year 2022, North America owned a 35% market share. This is due to the existence of key market competitors as well as significant expenditure in the development of innovative treatments. For instance, in October 2021, researchers from Duke University and the University of California discovered kenpaullone, a novel medication for chronic pain, with the KKC2 gene, which is required for pain signal suppression. Such increasing innovation aids in the expansion of the Postoperative Pain Market share.

Asia-Pacific is forecast to expand at the fastest CAGR between 2022 and 2030. This is due to an increase in hospitalizations for surgery. According to the Asian Development Bank, almost 645,000 people are killed in traffic accidents throughout Asia and the Pacific each year. With such a high rate of hospitalization for surgeries and an increase in the number of accidents in this region, demand for postoperative pain management would increase, fueling the expansion of the Postoperative Pain Market share over the projected period.

Key Highlights of the Report

The global Postoperative Pain Medication Market is segmented by medication type, role of administration, surgical procedure, end-users, patient profileand region.The oral and opioid categories maintained a strong market share. Furthermore, ambulatory surgical centres are the fastest growing sector of the postoperative pain treatment industry, and the pediatric patients sector has the highest compound annual growth rate (CAGR), with North Amercaleading the market growth.

The key market drivers include the expanding number of surgical operations globally, growing awareness of the need of excellent pain management, and innovations in pharmaceutical formulations and medicine delivery modalities. Furthermore, the primary issues confronting the postoperative pain management market are the need for effective pain control while minimizing side effects, the heterogeneity in individual pain experiences and treatment reactions, and the need for continuous monitoring and adjustment of pain management strategies.

Nonetheless, North America will have a 35% market share in 2022. This is because there are big market rivals as well as significant investment in the development of innovative medicines. Furthermore, the Asia-Pacific region is expected to develop at the quickest CAGR between 2022 and 2027. This is attributed to an increase in surgical hospitalizations. Each year, about 645,000 people are killed in road accidents across Asia and the Pacific, according to the Asian Development Bank.

What Elements Are Driving the Global Market for Postoperative Pain Medication?

The increasing number of surgical procedures worldwide, rising knowledge about the necessity of good pain management, and advancements in pharmaceutical formulations and medication delivery techniques are the primary market drivers.

What Are The Main Obstacles That The Global Postoperative Pain Medication Market Faces?

The primary issues confronting the postoperative pain medication market are the requirement for effective pain control while reducing side effects, the heterogeneity in individual pain experiences and reactions to treatment, and the necessity for continual monitoring and adjustment of pain management strategies. Furthermore, there may be access issues to specialized pain management services, as well as a need for increased education and understanding about the necessity of comprehensive pain treatment in the healthcare community.

What Market Development Prospects Are There For Postoperative Pain Medication Globally?

The use of multimodal techniques, integration of digital health technology for real-time monitoring, and collaboration between healthcare providers and patients to establish tailored pain management regimens are among the significant potential in the postoperative pain medication market. These prospects seek to improve pain relief, patient satisfaction, and recovery outcomes in postoperative care.

Market Drivers

The global Postoperative Pain Medication Market is driven by several factors. The following are the key drivers of the global Postoperative Pain Medication Market:

Rising Prevalence Of Chronic Diseases

The rising prevalence of chronic diseases such as arthritis and cancer, both of which cause significant pain, raises the demand for pain management and treatment. The World Cancer Research Fund estimates that there will be approximately 18.1 million cancer cases in 2020. Cancer pain can be caused by a tumour pressing against bones, organs, or nerves. For example, compression of the spinal cord caused discomfort when a tumour penetrated the spine and exerted pressure on the spinal cord’s nerves. Spinal anesthesia has been shown to be beneficial in the treatment of severe pain in reducing spinal discomfort.The increasing prevalence of chronic diseases such as arthritis and cancer, as well as the necessity for pain management treatment, drive the growth of the Postoperative Pain Industry throughout the projected period of 2022-2027.

Expansion Of Ambulatory Surgical Centres

The expanding number of ambulatory surgery centres (ASCs) boosts the Postoperative Pain Market’s growth rate. This is due to the lower cost of treatment when compared to a hospital stay and the more convenient service style of ambulatory surgery centres. Furthermore, the expanding senior population drives up demand for ambulatory surgical centres. According to the Association of Wisconsin Surgery Centres, there are roughly 5,300 ambulatory surgery centres in the United States, with ASCs outnumbering hospitals in several states. Furthermore, surgery centres undertake approximately 23 million surgeries per year, and the Centres for Medicare & Medicaid Services (CMS) approves novel techniques for the ASC environment each year, propelling the Postoperative Pain Industry forward.

Market Restraints

The global Postoperative Pain Medication Market faces some challenges that may hinder its growth. These include the following:

Balancing Effective Pain Control And Side Effect Minimization In Postoperative Pain Medication

One of the most difficult problems is striking a fine balance between efficiently treating pain and limiting harmful adverse effects of pain drugs. It is critical to select the proper medicine combination and dose to offer significant pain relief without producing undesired side effects such as sleepiness, nausea, or respiratory depression. To achieve this balance, pain management regimens must be carefully monitored and adjusted to guarantee maximum patient comfort and safety during the recovery process. To adapt pain management measures, healthcare practitioners must consider specific patient criteria such as age, medical history, and drug sensitivities. Furthermore, continuing research and advances in pain management approaches are aimed at addressing this issue and improving patient outcomes in postoperative care.

Opportunities

The global Postoperative Pain Medication Market offers significant growth opportunities. These include the following:

Multimodal Approaches to Improving Patient Care and Outcomes

The market’s use of multimodal techniques offers a potential to improve patient care and results. Healthcare practitioners can construct complete treatment regimens that address the many components of a patient’s disease by integrating diverse modalities, such as drugs, physical therapy, and alternative therapies. This method provides for a more individualized and customised approach to patient treatment, taking into consideration individual requirements and preferences. Multimodal techniques can also serve to lessen dependency on a single treatment modality, thereby lowering the risk of adverse effects or medication resistance.

Competitive Landscape

Key Players

The global Postoperative Pain Medication Market is highly competitive, with several key players. Some of the major players in the market and their market share are as follows:

  • AbbVie (Allergan)
  • Heron Therapeutics
  • Cali Biosciences
  • Acadia Pharmaceuticals
  • Virpax Pharmaceuticals
  • GlaxoSmithKline Plc
  • Pacira Pharmaceuticals Inc.
  • Johnson & Johnson (Janssen Pharmaceuticals)
  • AFT Pharmaceuticals
  • Alembic Pharmaceuticals
  • InvaGen Pharmaceuticals Inc.
  • SiteOne Therapeutics
  • Pfizer Inc.

These organizations prioritize medication type innovation, disease area expansion, and mergers and acquisitions to stay competitive.

The global postoperative pain medication market’s key players continually seek to stay ahead by offering new Medication Types and developments.

In March 2022, Cali Biosciences Co., Ltd., a biopharmaceutical firm focused on the research and development of novel pharmaceuticals, published positive Phase IIb findings for its perioperative long-acting analgesic medication CPL-01.

In January 2022, Pfizer Inc has entered into a collaboration agreement with Acuitas therapies to develop lipid nanoparticle (LNP) delivery systems for messenger RNA (mRNA)-based therapies. Pfizer has the possibility under this research and option agreement to license Acuitas’ LNP technology for up to ten targets for vaccine or therapeutic development on a non-exclusive basis.

In January 2020, Novartis AG has completed its acquisition of The Medicines Company through the merging of its indirect wholly-owned subsidiary, Medusa merging Corporation.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Summary of Key Findings

  • The growth of ambulatory surgery centres expands the postoperative pain market to drive market growth.
  • Market segmented by medication type, role of administration, surgical procedure, patient profile. end-users and region
  • Ambulatory surgical centres are the fastest growing segment of the postoperative pain treatment industry.
  • The oral category retained a commanding market share and the intravenous category holds the second largest share in the market
  • North America is leading market growth; the market is highly competitive with key players including AbbVie (Allergan), Heron Therapeutics, Cali Biosciences, Acadia Pharmaceuticals, Virpax Pharmaceuticals, GlaxoSmithKline Plc, Pacira Pharmaceuticals Inc

Future Outlook

  • There is a growing need for effective postoperative pain management treatments.
  • Improvements in medicine composition and administration methods.
  • A greater emphasis on individualized pain management approaches.
  • An increase in the use of non-pharmacological pain treatment strategies.
  • Use of digital health technologies to manage postoperative pain.
  • Partnerships and collaborations between pharmaceutical corporations and healthcare professionals.
  • Global postoperative pain market expansion, with emerging nations driving growth.
  • Raising awareness and providing information about postoperative pain management.

Segmentation

  • By Medication Type:
    • Non-Opioid Analgesics (NSAIDs, Acetaminophen, etc.)
    • Opioid Analgesics (Morphine, Oxycodone, Hydrocodone, etc.)
    • Local Anesthetics
    • Adjunctive Medications (Muscle Relaxants, Antidepressants, etc.)
  • By Route of Administration:
    • Oral
    • Intravenous
    • Intramuscular
    • Transdermal
    • Epidural
  • By Surgical Procedure:
    • Orthopedic Surgeries
    • Abdominal Surgeries
    • Cardiothoracic Surgeries
    • Neurosurgical Procedures
    • Gynecological Surgeries
    • Others
  • By End-Users:
    • Hospitals and Clinics
    • Ambulatory Surgery Centers
    • Pain Management Centers
  • By Patient Profile:
    • Adult Patients
    • Pediatric Patients
    • Geriatric Patients
  • By Region
    • North America
      • US
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • UK.
      • Italy
      • Spain
      • Rest of Europe
    • Asia Pacific
      • China
      • Japan
      • India
      • South Korea
      • South-east Asia
      • Rest of Asia Pacific
    • Latin America
      • Brazil
      • Argentina
      • Rest of Latin America
    • Middle East & Africa
      • GCC Countries
      • South Africa
      • Rest of Middle East and Africa

Adjacent Markets

In the Postoperative Pain Medication Market, there are several adjacent markets which has high revenue growth opportunities. The key adjacent markets for Postoperative Pain Medication Market-

1. Preface

1.1. Report Description

1.1.1. Purpose of the Report

1.1.2. Target Audience

1.1.3. USP and Key Offerings

1.2. Research Scope

1.3. Market Introduction

 

2. Executive Summary

2.1. Market Snapshot: Global Postoperative Pain Medication Market

2.1.1. Global Postoperative Pain Medication Market, By Medication Type

2.1.2. Global Postoperative Pain Medication Market, By Route of Administration

2.1.3. Global Postoperative Pain Medication Market, By Surgical Procedure

2.1.4. Global Postoperative Pain Medication Market, By End-Users

2.1.5. Global Postoperative Pain Medication Market, By Patient Profile

2.1.6. Global Postoperative Pain Medication Market, By Region

2.2. Insights from Primary Respondents

 

3. Market Dynamics & Factors Analysis

3.1. Introduction

3.1.1. Global Postoperative Pain Medication Market Value, 2017-2030, (US$ Mn)

3.1.2. Y-o-Y Growth Trend Analysis

3.2. Market Dynamics

3.2.1. Postoperative Pain Medication Market Drivers

3.2.2. Postoperative Pain Medication Market Restraints

3.2.3. Postoperative Pain Medication Market Opportunities

3.2.4. Major Postoperative Pain Medication Industry Challenges

3.3. Growth and Development Patterns

3.4. Investment Feasibility Analysis

3.5. Market Opportunity Analysis

3.5.1. Medication Type

3.5.2. Route of Administration

3.5.3. Surgical Procedure

3.5.4. End-Users

3.5.5. Patient Profile

3.5.6. Sales Channel

3.5.7. Price Range

3.5.8. Geography

 

4. Market Competitive Landscape Analysis

4.1. Company Market Share Analysis, 2022

4.1.1. Global Postoperative Pain Medication Market: Company Market Share, Value 2022

4.1.2. Global Postoperative Pain Medication Market: Top 6 Company Market Share, Value 2022

4.1.3. Global Postoperative Pain Medication Market: Top 3 Company Market Share, Value 2022

4.2. Global Postoperative Pain Medication Market: Company Revenue Share Analysis, 2022

4.3. Company Assessment Metrics, 2022

4.3.1. Stars

4.3.2. Emerging Leaders

4.3.3. Pervasive Players

4.3.4. Participants

4.4. Startups/ SMEs Assessment Metrics, 2022

4.4.1. Progressive Companies

4.4.2. Responsive Companies

4.4.3. Dynamic Companies

4.4.4. Starting Blocks

4.5. Strategic Development

4.5.1. Acquisition and Mergers

4.5.2. New Medication Type Launch

4.5.3. Regional Expansion

4.5.4. Partnerships

4.6. Key Player Medication Type Matrix

4.7. Potential for New Players in the Global Postoperative Pain Medication Market

 

5. Premium Insights

5.1. STAR (Situation, Task, Action, Results) Analysis

5.2. Porter’s Five Forces Analysis

5.2.1. Threat of New Entrants

5.2.2. Bargaining Power of Buyers/Consumers

5.2.3. Bargaining Power of Suppliers

5.2.4. Threat of Substitute Types

5.2.5. Intensity of Competitive Rivalry

5.3. PESTEL Analysis

5.3.1. Political Factors

5.3.2. Economic Factors

5.3.3. Social Factors

5.3.4. Technological Factors

5.3.5. Environmental Factors

5.3.6. Legal Factors

5.4. Key Market Trends

5.4.1. Demand Side Trends

5.4.2. Supply Side Trends

5.5. Value Chain Analysis

5.6. Technology Analysis

5.6.1. Abdominal Surgeries in the global market

5.6.2. Patent Analysis

5.6.3. Emerging technologies and their potential disruption to the market

5.7. Consumer Behaviour Analysis

5.7.1. Consumer Preferences and Expectations

5.7.2. Factors Influencing Consumer Buying Decisions

5.7.2.1. North America

5.7.2.2. Europe

5.7.2.3. Asia Pacific

5.7.2.4. Latin America

5.7.2.5. Middle East and Africa

5.7.3. Consumer Pain Points

5.8. Analysis and Recommendations

5.9. Adjacent Market Analysis

 

6. Market Positioning of Key Players, 2022

6.1. Company market share of key players, 2022

6.2. Competitive Benchmarking

6.3. Market Positioning of Key Vendors

6.4. Geographical Presence Analysis

6.5. Major Strategies Adopted by Key Players

6.5.1. Key Strategies Analysis

6.5.2. Mergers and Acquisitions

6.5.3. Partnerships

6.5.4. Medication Type Launch

6.5.5. Geographical Expansion

6.5.6. Autoimmune Diseases

 

7. Impact Analysis of COVID 19 and Russia – Ukraine War on Postoperative Pain Medication Market

7.1. Ukraine-Russia War Impact

7.1.1. Uncertainty and Economic Instability

7.1.2. Supply chain disruptions

7.1.3. Regional market shifts

7.1.4. Shift in government priorities

7.2. COVID-19 Impact Analysis

7.2.1. Supply Chain Disruptions

7.2.2. Demand Fluctuations

7.2.3. Shift in Medication Type Mix

7.2.4. Reduced Industrial Activity

7.2.5. Regional Impact Analysis

7.2.5.1. North America

7.2.5.2. Europe

7.2.5.3. Asia Pacific

7.2.5.4. Latin America

7.2.5.5. Middle East and Africa

 

8. Global Postoperative Pain Medication Market, By Medication Type

8.1. Global Postoperative Pain Medication Market Overview, By Medication Type

8.1.1. Global Postoperative Pain Medication Market Revenue Share, By Medication Type, 2022 Vs 2030 (in %)

8.2. Non-Opioid Analgesics (NSAIDs, Acetaminophen, etc.)

8.2.1. Global Postoperative Pain Medication Market, By NON-OPIOID ANALGESICS (NSAIDS, ACETAMINOPHEN, ETC.), By Region, 2017-2030 (US$ Mn)

8.2.2. Market Dynamics for NON-OPIOID ANALGESICS (NSAIDS, ACETAMINOPHEN, ETC.)

8.2.2.1. Drivers

8.2.2.2. Restraints

8.2.2.3. Opportunities

8.2.2.4. Trends

8.3. Opioid Analgesics (Morphine, Oxycodone, Hydrocodone, etc.)

8.3.1. Global Postoperative Pain Medication Market, By OPIOID ANALGESICS (MORPHINE, OXYCODONE, HYDROCODONE, ETC.), By Region, 2017-2030 (US$ Mn)

8.3.2. Market Dynamics for OPIOID ANALGESICS (MORPHINE, OXYCODONE, HYDROCODONE, ETC.)

8.3.2.1. Drivers

8.3.2.2. Restraints

8.3.2.3. Opportunities

8.3.2.4. Trends

8.4. Local Anesthetics

8.4.1. Global Postoperative Pain Medication Market, By Local Anesthetics, By Region, 2017-2030 (US$ Mn)

8.4.2. Market Dynamics for Local Anesthetics

8.4.2.1. Drivers

8.4.2.2. Restraints

8.4.2.3. Opportunities

8.4.2.4. Trends

8.5. Adjunctive Medications (Muscle Relaxants, Antidepressants, etc.)

8.5.1. Global Postoperative Pain Medication Market, By Adjunctive Medications (Muscle Relaxants, Antidepressants, etc.), By Region, 2017-2030 (US$ Mn)

8.5.2. Market Dynamics for Adjunctive Medications (Muscle Relaxants, Antidepressants, etc.)

8.5.2.1. Drivers

8.5.2.2. Restraints

8.5.2.3. Opportunities

8.5.2.4. Trends

 

9. Global Postoperative Pain Medication Market, By Route of Administration

9.1. Global Postoperative Pain Medication Market Overview, By Route of Administration

9.1.1. Global Postoperative Pain Medication Market Revenue Share, By Route of Administration, 2022 Vs 2030 (in %)

9.2. Oral

9.2.1. Global Postoperative Pain Medication Market, By Oral, By Region, 2017-2030 (US$ Mn)

9.2.2. Market Dynamics for Oral

9.2.2.1. Drivers

9.2.2.2. Restraints

9.2.2.3. Opportunities

9.2.2.4. Trends

9.3. Intravenous

9.3.1. Global Postoperative Pain Medication Market, By Intravenous, By Region, 2017-2030 (US$ Mn)

9.3.2. Market Dynamics for Intravenous

9.3.2.1. Drivers

9.3.2.2. Restraints

9.3.2.3. Opportunities

9.3.2.4. Trends

 

10. Global Postoperative Pain Medication Market, By Surgical Procedure

10.1. Global Postoperative Pain Medication Market Overview, By Surgical Procedure

10.1.1. Global Postoperative Pain Medication Market Revenue Share, By Surgical Procedure, 2022 Vs 2030 (in %)

10.2. Orthopedic Surgeries

10.2.1. Global Postoperative Pain Medication Market, By Orthopedic Surgeries, By Region, 2017-2030 (US$ Mn)

10.2.2. Market Dynamics for Orthopedic Surgeries

10.2.2.1. Drivers

10.2.2.2. Restraints

10.2.2.3. Opportunities

10.2.2.4. Trends

10.3. Abdominal Surgeries

10.3.1. Global Postoperative Pain Medication Market, By Orthopedic SurgeriesI, By Region, 2017-2030 (US$ Mn)

10.3.2. Market Dynamics for Orthopedic SurgeriesI

10.3.2.1. Drivers

10.3.2.2. Restraints

10.3.2.3. Opportunities

10.3.2.4. Trends

10.4. Cardiothoracic Surgeries

10.4.1. Global Postoperative Pain Medication Market, By Orthopedic SurgeriesII, By Region, 2017-2030 (US$ Mn)

10.4.2. Market Dynamics for Orthopedic SurgeriesII

10.4.2.1. Drivers

10.4.2.2. Restraints

10.4.2.3. Opportunities

10.4.2.4. Trends

 

11. Global Postoperative Pain Medication Market, By End-Users

11.1. Global Postoperative Pain Medication Market Overview, by End-Users

11.1.1. Global Postoperative Pain Medication Market Revenue Share, By End-Users, 2022 Vs 2030 (in %)

11.2. Hospitals and Clinics

11.2.1. Global Postoperative Pain Medication Market, By Hospitals and Clinics, By Region, 2017-2030 (US$ Mn)

11.2.2. Market Dynamics for Hospitals and Clinics

11.2.2.1. Drivers

11.2.2.2. Restraints

11.2.2.3. Opportunities

11.2.2.4. Trends

11.3. Ambulatory Surgery Centers

11.3.1. Global Postoperative Pain Medication Market, By Ambulatory Surgery Centers, By Region, 2017-2030 (US$ Mn)

11.3.2. Market Dynamics for Ambulatory Surgery Centers

11.3.2.1. Drivers

11.3.2.2. Restraints

11.3.2.3. Opportunities

11.3.2.4. Trends

 

12. Global Postoperative Pain Medication Market, By Patient Profile

12.1. Global Postoperative Pain Medication Market Overview, by Patient Profile

12.1.1. Global Postoperative Pain Medication Market Revenue Share, By Patient Profile, 2022 Vs 2030 (in %)

12.2. Adult Patients

12.2.1. Global Postoperative Pain Medication Market, By Adult Patients, By Region, 2017-2030 (US$ Mn)

12.2.2. Market Dynamics for Adult Patients

12.2.2.1. Drivers

12.2.2.2. Restraints

12.2.2.3. Opportunities

12.2.2.4. Trends

12.3. Pediatric Patients

12.3.1. Global Postoperative Pain Medication Market, By Pediatric Patients, By Region, 2017-2030 (US$ Mn)

12.3.2. Market Dynamics for Pediatric Patients

12.3.2.1. Drivers

12.3.2.2. Restraints

12.3.2.3. Opportunities

12.3.2.4. Trends

12.4. Geriatric Patients

12.4.1. Global Postoperative Pain Medication Market, By Geriatric Patients, By Region, 2017-2030 (US$ Mn)

12.4.2. Market Dynamics for Geriatric Patients

12.4.2.1. Drivers

12.4.2.2. Restraints

12.4.2.3. Opportunities

12.4.2.4. Trends

 

13. Global Postoperative Pain Medication Market, By Region

13.1. Global Postoperative Pain Medication Market Overview, by Region

13.1.1. Global Postoperative Pain Medication Market, By Region, 2022 vs 2030 (in%)

13.2. Medication Type

13.2.1. Global Postoperative Pain Medication Market, By Medication Type, 2017-2030 (US$ Mn)

13.3. Route of Administration

13.3.1. Global Postoperative Pain Medication Market, By Route of Administration, 2017-2030 (US$ Mn)

13.4. Surgical Procedure

13.4.1. Global Postoperative Pain Medication Market, By Surgical Procedure, 2017-2030 (US$ Mn)

13.5. End-Users

13.5.1. Global Postoperative Pain Medication Market, By End-Users, 2017-2030 (US$ Mn)

13.6. Patient Profile

13.6.1. Global Postoperative Pain Medication Market, By Patient Profile, 2017-2030 (US$ Mn)

 

14. North America Postoperative Pain Medication Market Analysis

14.1. Overview

14.1.1. Market Dynamics for North America

14.1.1.1. Drivers

14.1.1.2. Restraints

14.1.1.3. Opportunities

14.1.1.4. Trends

14.2. North America Postoperative Pain Medication Market, By Medication Type, 2017-2030(US$ Mn)

14.2.1. Overview

14.2.2. SRC Analysis

14.3. North America Postoperative Pain Medication Market, By Route of Administration, 2017-2030(US$ Mn)

14.3.1. Overview

14.3.2. SRC Analysis

14.4. North America Postoperative Pain Medication Market, By Surgical Procedure, 2017-2030(US$ Mn)

14.4.1. Overview

14.4.2. SRC Analysis

14.5. North America Postoperative Pain Medication Market, By End-Users, 2017-2030(US$ Mn)

14.5.1. Overview

14.5.2. SRC Analysis

14.6. North America Postoperative Pain Medication Market, by Patient Profile, 2017-2030(US$ Mn)

14.6.1. Overview

14.6.2. SRC Analysis

14.7. North America Postoperative Pain Medication Market, by Country, 2017-2030(US$ Mn)

14.7.1. North America Postoperative Pain Medication Market, by Country, 2022 Vs 2030 (in%)

14.7.2. U.S.

14.7.3. Canada

14.7.4. Mexico

 

15. Europe Postoperative Pain Medication Market Analysis

15.1. Overview

15.1.1. Market Dynamics for North America

15.1.1.1. Drivers

15.1.1.2. Restraints

15.1.1.3. Opportunities

15.1.1.4. Trends

15.2. Europe Postoperative Pain Medication Market, By Medication Type, 2017-2030(US$ Mn)

15.2.1. Overview

15.2.2. SRC Analysis

15.3. Europe Postoperative Pain Medication Market, By Route of Administration, 2017-2030(US$ Mn)

15.3.1. Overview

15.3.2. SRC Analysis

15.4. Europe Postoperative Pain Medication Market, By Surgical Procedure, 2017-2030(US$ Mn)

15.4.1. Overview

15.4.2. SRC Analysis

15.5. Europe Postoperative Pain Medication Market, By End-Users, 2017-2030(US$ Mn)

15.5.1. Overview

15.5.2. SRC Analysis

15.6. Europe Postoperative Pain Medication Market, by Patient Profile, 2017-2030(US$ Mn)

15.6.1. Overview

15.6.2. SRC Analysis

15.7. Europe Postoperative Pain Medication Market, by Country, 2017-2030 (US$ Mn)

15.7.1. Europe Postoperative Pain Medication Market, by Country, 2022 Vs 2030 (in%)

15.7.2. UK

15.7.3. France

15.7.4. Germany

15.7.5. Italy

15.7.6. Spain

15.7.7. Benelux

15.7.8. Russia

15.7.9. Rest of Europe

 

16. Asia Pacific Postoperative Pain Medication Market Analysis

16.1. Overview

16.1.1. Market Dynamics for North America

16.1.1.1. Drivers

16.1.1.2. Restraints

16.1.1.3. Opportunities

16.1.1.4. Trends

16.2. Asia Pacific Postoperative Pain Medication Market, By Medication Type, 2017-2030(US$ Mn)

16.2.1. Overview

16.2.2. SRC Analysis

16.3. Asia Pacific Postoperative Pain Medication Market, By Route of Administration, 2017-2030(US$ Mn)

16.3.1. Overview

16.3.2. SRC Analysis

16.4. Asia Pacific Postoperative Pain Medication Market, By Surgical Procedure, 2017-2030(US$ Mn)

16.4.1. Overview

16.4.2. SRC Analysis

16.5. Asia Pacific Postoperative Pain Medication Market, By End-Users, 2017-2030(US$ Mn)

16.5.1. Overview

16.5.2. SRC Analysis

16.6. Asia Pacific Postoperative Pain Medication Market, by Patient Profile, 2017-2030(US$ Mn)

16.6.1. Overview

16.6.2. SRC Analysis

16.7. Asia Pacific Postoperative Pain Medication Market, by Country, 2017-2030 (US$ Mn)

16.7.1. Asia Pacific Postoperative Pain Medication Market, by Country, 2022 Vs 2030 (in%)

16.7.2. China

16.7.3. Japan

16.7.4. India

16.7.5. South Korea

16.7.6. South East Asia

16.7.7. Rest of Asia Pacific

 

17. Latin America Postoperative Pain Medication Market Analysis

17.1. Overview

17.1.1. Market Dynamics for North America

17.1.1.1. Drivers

17.1.1.2. Restraints

17.1.1.3. Opportunities

17.1.1.4. Trends

17.2. Latin America Postoperative Pain Medication Market, By Medication Type, 2017-2030(US$ Mn)

17.2.1. Overview

17.2.2. SRC Analysis

17.3. Latin America Postoperative Pain Medication Market, By Route of Administration, 2017-2030(US$ Mn)

17.3.1. Overview

17.3.2. SRC Analysis

17.4. Latin America Postoperative Pain Medication Market, By Surgical Procedure, 2017-2030(US$ Mn)

17.4.1. Overview

17.4.2. SRC Analysis

17.5. Latin America Postoperative Pain Medication Market, By End-Users, 2017-2030(US$ Mn)

17.5.1. Overview

17.5.2. SRC Analysis

17.6. Latin America Postoperative Pain Medication Market, by Patient Profile, 2017-2030(US$ Mn)

17.6.1. Overview

17.6.2. SRC Analysis

17.7. Latin America Postoperative Pain Medication Market, by Country, 2017-2030 (US$ Mn)

17.7.1. Latin America Postoperative Pain Medication Market, by Country, 2022 Vs 2030 (in%)

17.7.2. Brazil

17.7.3. Argentina

17.7.4. Rest of Latin America

 

18. Middle East Postoperative Pain Medication Market Analysis

18.1. Overview

18.1.1. Market Dynamics for North America

18.1.1.1. Drivers

18.1.1.2. Restraints

18.1.1.3. Opportunities

18.1.1.4. Trends

18.2. Middle East Postoperative Pain Medication Market, By Medication Type, 2017-2030(US$ Mn)

18.2.1. Overview

18.2.2. SRC Analysis

18.3. Middle East Postoperative Pain Medication Market, By Route of Administration, 2017-2030(US$ Mn)

18.3.1. Overview

18.3.2. SRC Analysis

18.4. Middle East Postoperative Pain Medication Market, By Surgical Procedure, 2017-2030(US$ Mn)

18.4.1. Overview

18.4.2. SRC Analysis

18.5. Middle East Postoperative Pain Medication Market, By End-Users, 2017-2030(US$ Mn)

18.5.1. Overview

18.5.2. SRC Analysis

18.6. Middle East Postoperative Pain Medication Market, by Patient Profile, 2017-2030(US$ Mn)

18.6.1. Overview

18.6.2. SRC Analysis

18.7. Middle East Postoperative Pain Medication Market, by Country, 2017-2030 (US$ Mn)

18.7.1. Middle East Postoperative Pain Medication Market, by Country, 2022 Vs 2030 (in%)

18.7.2. UAE

18.7.3. Saudi Arabia

18.7.4. Rest of Middle East

 

19. Africa Postoperative Pain Medication Market Analysis

19.1. Overview

19.1.1. Market Dynamics for North America

19.1.1.1. Drivers

19.1.1.2. Restraints

19.1.1.3. Opportunities

19.1.1.4. Trends

19.2. Africa Postoperative Pain Medication Market, By Medication Type, 2017-2030(US$ Mn)

19.2.1. Overview

19.2.2. SRC Analysis

19.3. Africa Postoperative Pain Medication Market, By Route of Administration, 2017-2030(US$ Mn)

19.3.1. Overview

19.3.2. SRC Analysis

19.4. Africa Postoperative Pain Medication Market, By Surgical Procedure, 2017-2030(US$ Mn)

19.4.1. Overview

19.4.2. SRC Analysis

19.5. Africa Postoperative Pain Medication Market, By End-Users, 2017-2030(US$ Mn)

19.5.1. Overview

19.5.2. SRC Analysis

19.6. Africa Postoperative Pain Medication Market, by Patient Profile, 2017-2030(US$ Mn)

19.6.1. Overview

19.6.2. SRC Analysis

19.7. Africa Postoperative Pain Medication Market, by Country, 2017-2030 (US$ Mn)

19.7.1. Middle East Postoperative Pain Medication Market, by Country, 2022 Vs 2030 (in%)

19.7.2. South Africa

19.7.3. Egypt

19.7.4. Rest of Africa

 

20. Company Profiles

20.1. AbbVie (Allergan)

20.1.1. Company Overview

20.1.2. Medication Types/Services Portfolio

20.1.3. Geographical Presence

20.1.4. SWOT Analysis

20.1.5. Financial Summary

20.1.5.1. Market Revenue and Net Profit (2019-2022)

20.1.5.2. Business Segment Revenue Analysis

20.1.5.3. Geographical Revenue Analysis

20.2. Heron Therapeutics

20.3. Cali Biosciences

20.4. Acadia Pharmaceuticals

20.5. Virpax Pharmaceuticals

20.6. GlaxoSmithKline Plc

20.7. Pacira Pharmaceuticals Inc.

20.8. Johnson & Johnson (Janssen Pharmaceuticals)

20.9. AFT Pharmaceuticals

20.10. Alembic Pharmaceuticals

20.11. InvaGen Pharmaceuticals Inc.

20.12. SiteOne Therapeutics

20.13. Pfizer Inc.

 

21. Research Methodology

21.1. Research Methodology

21.2. Orthopedic Surgeries – Secondary Research

21.3. Orthopedic SurgeriesI – Data Modelling

21.3.1. Company Share Analysis Model

21.3.2. Revenue Based Modelling

21.4. Orthopedic SurgeriesII – Primary Research

21.5. Research Limitations

21.5.1. Assumptions

List of Figures

FIG. 1 Global Postoperative Pain Medication Market: Research Methodology

FIG. 2 Market Size Estimation – Top Down & Bottom up Approach

FIG. 3 Global Postoperative Pain Medication Market Segmentation

FIG. 4 Global Postoperative Pain Medication Market, By Medication Type, 2022 (US$ Mn)

FIG. 5 Global Postoperative Pain Medication Market, By Route of Administration, 2022 (US$ Mn)

FIG. 6 Global Postoperative Pain Medication Market, By Surgical Procedure, 2022 (US$ Mn)

FIG. 7 Global Postoperative Pain Medication Market, by End-Users, 2022 (US$ Mn)

FIG. 8 Global Postoperative Pain Medication Market, by Patient Profile, 2022 (US$ Mn)

FIG. 9 Global Postoperative Pain Medication Market, by Geography, 2022 (US$ Mn)

FIG. 10 Attractive Investment Proposition, By Medication Type, 2022

FIG. 11 Attractive Investment Proposition, By Route of Administration, 2022

FIG. 12 Attractive Investment Proposition, By Surgical Procedure, 2022

FIG. 13 Attractive Investment Proposition, By End-Users, 2022

FIG. 14 Attractive Investment Proposition, by Patient Profile, 2022

FIG. 15 Attractive Investment Proposition, by Geography, 2022

FIG. 16 Global Market Share Analysis of Key Postoperative Pain Medication Market Manufacturers, 2022

FIG. 17 Global Market Positioning of Key Postoperative Pain Medication Market Manufacturers, 2022

FIG. 18 Global Postoperative Pain Medication Market Value Contribution, By Medication Type, 2022 & 2030 (Value %)

FIG. 19 Global Postoperative Pain Medication Market, by NON-OPIOID ANALGESICS (NSAIDS, ACETAMINOPHEN, ETC.), Value, 2017-2030 (US$ Mn)

FIG. 20 Global Postoperative Pain Medication Market, by OPIOID ANALGESICS (MORPHINE, OXYCODONE, HYDROCODONE, ETC.), Value, 2017-2030 (US$ Mn)

FIG. 21 Global Postoperative Pain Medication Market, by Local Anesthetics, Value, 2017-2030 (US$ Mn)

FIG. 22 Global Postoperative Pain Medication Market, by Adjunctive Medications (Muscle Relaxants, Antidepressants, etc.), Value, 2017-2030 (US$ Mn)

FIG. 23 Global Postoperative Pain Medication Market, by Autoimmune Diseases, Value, 2017-2030 (US$ Mn)

FIG. 24 Global Postoperative Pain Medication Market Value Contribution, By Route of Administration, 2022 & 2030 (Value %)

FIG. 25 Global Postoperative Pain Medication Market, by Oral, Value, 2017-2030 (US$ Mn)

FIG. 26 Global Postoperative Pain Medication Market, by Intravenous, Value, 2017-2030 (US$ Mn)

FIG. 27 Global Postoperative Pain Medication Market Value Contribution, By Surgical Procedure, 2022 & 2030 (Value %)

FIG. 28 Global Postoperative Pain Medication Market, by Orthopedic Surgeries, Value, 2017-2030 (US$ Mn)

FIG. 29 Global Postoperative Pain Medication Market, by Abdominal Surgeries, Value, 2017-2030 (US$ Mn)

FIG. 30 Global Postoperative Pain Medication Market, by Cardiothoracic Surgeries, Value, 2017-2030 (US$ Mn)

FIG. 31 Global Postoperative Pain Medication Market Value Contribution, By End-Users, 2022 & 2030 (Value %)

FIG. 32 Global Postoperative Pain Medication Market, by Hospitals and Clinics, Value, 2017-2030 (US$ Mn)

FIG. 33 Global Postoperative Pain Medication Market, by Ambulatory Surgery Centers, Value, 2017-2030 (US$ Mn)

FIG. 34 Global Postoperative Pain Medication Market Value Contribution, By Patient Profile, 2022 & 2030 (Value %)

FIG. 35 Global Postoperative Pain Medication Market, by Adult Patients, Value, 2017-2030 (US$ Mn)

FIG. 36 Global Postoperative Pain Medication Market, by Pediatric Patients, Value, 2017-2030 (US$ Mn)

FIG. 37 Global Postoperative Pain Medication Market, by Geriatric Patients, Value, 2017-2030 (US$ Mn)

FIG. 38 North America Postoperative Pain Medication Market, 2017-2030 (US$ Mn)

FIG. 39 U.S. Postoperative Pain Medication Market, 2017-2030 (US$ Mn)

FIG. 40 Canada Postoperative Pain Medication Market, 2017-2030 (US$ Mn)

FIG. 41 MexicoPostoperative Pain Medication Market, 2017-2030 (US$ Mn)

FIG. 42 Europe Postoperative Pain Medication Market, 2017-2030 (US$ Mn)

FIG. 43 Germany Postoperative Pain Medication Market, 2017-2030 (US$ Mn)

FIG. 44 France Postoperative Pain Medication Market, 2017-2030 (US$ Mn)

FIG. 45 U.K. Postoperative Pain Medication Market, 2017-2030 (US$ Mn)

FIG. 46 Italy Postoperative Pain Medication Market, 2017-2030 (US$ Mn)

FIG. 47 Spain Postoperative Pain Medication Market, 2017-2030 (US$ Mn)

FIG. 48 BeneluxPostoperative Pain Medication Market, 2017-2030 (US$ Mn)

FIG. 49 RussiaPostoperative Pain Medication Market, 2017-2030 (US$ Mn)

FIG. 50 Rest of Europe Postoperative Pain Medication Market, 2017-2030 (US$ Mn)

FIG. 51 Asia Pacific Postoperative Pain Medication Market, 2017-2030 (US$ Mn)

FIG. 52 China Postoperative Pain Medication Market, 2017-2030 (US$ Mn)

FIG. 53 Japan Postoperative Pain Medication Market, 2017-2030 (US$ Mn)

FIG. 54 India Postoperative Pain Medication Market, 2017-2030 (US$ Mn)

FIG. 55 South Korea Postoperative Pain Medication Market, 2017-2030 (US$ Mn)

FIG. 56 South-East Asia Postoperative Pain Medication Market, 2017-2030 (US$ Mn)

FIG. 57 Rest of Asia Pacific Postoperative Pain Medication Market, 2017-2030 (US$ Mn)

FIG. 58 Latin America Postoperative Pain Medication Market, 2017-2030 (US$ Mn)

FIG. 59 Brazil Postoperative Pain Medication Market, 2017-2030 (US$ Mn)

FIG. 60 ArgentinaPostoperative Pain Medication Market, 2017-2030 (US$ Mn)

FIG. 61 Rest of Latin America Postoperative Pain Medication Market, 2017-2030 (US$ Mn)

FIG. 62 Middle East Postoperative Pain Medication Market, 2017-2030 (US$ Mn)

FIG. 63 UAEPostoperative Pain Medication Market, 2017-2030 (US$ Mn)

FIG. 64 Saudi ArabiaPostoperative Pain Medication Market, 2017-2030 (US$ Mn)

FIG. 65 Rest of Middle East Postoperative Pain Medication Market, 2017-2030 (US$ Mn)

FIG. 66 AfricaPostoperative Pain Medication Market, 2017-2030 (US$ Mn)

FIG. 67 South Africa Postoperative Pain Medication Market, 2017-2030 (US$ Mn)

FIG. 68 EgyptPostoperative Pain Medication Market, 2017-2030 (US$ Mn)

FIG. 69 Rest of Africa Postoperative Pain Medication Market, 2017-2030 (US$ Mn)

 

List of Tables

TABLE 1 Market Snapshot: Global Postoperative Pain Medication Market

TABLE 2 Global Postoperative Pain Medication Market: Drivers Impact Analysis

TABLE 3 Global Postoperative Pain Medication Market: Market Restraints Impact Analysis

TABLE 4 Global Postoperative Pain Medication Market, by Competitive Benchmarking, 2022

TABLE 5 Global Postoperative Pain Medication Market, by Geographical Presence Analysis, 2022

TABLE 6 Global Postoperative Pain Medication Market, by Key Strategies Analysis, 2022

TABLE 7 Global Postoperative Pain Medication Market, by NON-OPIOID ANALGESICS (NSAIDS, ACETAMINOPHEN, ETC.), By Region, 2017-2022 (US$ Mn)

TABLE 8 Global Postoperative Pain Medication Market, by NON-OPIOID ANALGESICS (NSAIDS, ACETAMINOPHEN, ETC.), By Region, 2023-2030 (US$ Mn)

TABLE 9 Global Postoperative Pain Medication Market, by OPIOID ANALGESICS (MORPHINE, OXYCODONE, HYDROCODONE, ETC.), By Region, 2017-2022 (US$ Mn)

TABLE 10 Global Postoperative Pain Medication Market, by OPIOID ANALGESICS (MORPHINE, OXYCODONE, HYDROCODONE, ETC.), By Region, 2023-2030 (US$ Mn)

TABLE 11 Global Postoperative Pain Medication Market, by Oral, By Region, 2017-2022 (US$ Mn)

TABLE 12 Global Postoperative Pain Medication Market, by Oral, By Region, 2023-2030 (US$ Mn)

TABLE 13 Global Postoperative Pain Medication Market, by Intravenous, By Region, 2017-2022 (US$ Mn)

TABLE 14 Global Postoperative Pain Medication Market, by Intravenous, By Region, 2023-2030 (US$ Mn)

TABLE 15 Global Postoperative Pain Medication Market, by Orthopedic Surgeries, By Region, 2017-2022 (US$ Mn)

TABLE 16 Global Postoperative Pain Medication Market, by Orthopedic Surgeries, By Region, 2023-2030 (US$ Mn)

TABLE 17 Global Postoperative Pain Medication Market, by Abdominal Surgeries, By Region, 2017-2022 (US$ Mn)

TABLE 18 Global Postoperative Pain Medication Market, by Abdominal Surgeries, By Region, 2023-2030 (US$ Mn)

TABLE 19 Global Postoperative Pain Medication Market, by Cardiothoracic Surgeries, By Region, 2017-2022 (US$ Mn)

TABLE 20 Global Postoperative Pain Medication Market, by Cardiothoracic Surgeries, By Region, 2023-2030 (US$ Mn)

TABLE 21 Global Postoperative Pain Medication Market, by Hospitals and Clinics, By Region, 2017-2022 (US$ Mn)

TABLE 22 Global Postoperative Pain Medication Market, by Hospitals and Clinics, By Region, 2023-2030 (US$ Mn)

TABLE 23 Global Postoperative Pain Medication Market, by Ambulatory Surgery Centers, By Region, 2017-2022 (US$ Mn)

TABLE 24 Global Postoperative Pain Medication Market, by Ambulatory Surgery Centers, By Region, 2023-2030 (US$ Mn)

TABLE 25 Global Postoperative Pain Medication Market, by Adult Patients, By Region, 2017-2022 (US$ Mn)

TABLE 26 Global Postoperative Pain Medication Market, by Adult Patients, By Region, 2023-2030 (US$ Mn)

TABLE 27 Global Postoperative Pain Medication Market, By Medication Type, 2017-2022 (US$ Mn)

TABLE 28 Global Postoperative Pain Medication Market, By Medication Type, 2023-2030 (US$ Mn)

TABLE 29 Global Postoperative Pain Medication Market, By Route of Administration, 2017-2022 (US$ Mn)

TABLE 30 Global Postoperative Pain Medication Market, By Route of Administration, 2023-2030 (US$ Mn)

TABLE 31 Global Postoperative Pain Medication Market, By Surgical Procedure, 2017-2022 (US$ Mn)

TABLE 32 Global Postoperative Pain Medication Market, By Surgical Procedure, 2023-2030 (US$ Mn)

TABLE 33 Global Postoperative Pain Medication Market, By End-Users, By Region, 2017-2022 (US$ Mn)

TABLE 34 Global Postoperative Pain Medication Market, By End-Users, By Region, 2023-2030 (US$ Mn)

TABLE 35 Global Postoperative Pain Medication Market, by Patient Profile, 2017-2022 (US$ Mn)

TABLE 36 Global Postoperative Pain Medication Market, by Region, 2017-2022 (US$ Mn)

TABLE 37 Global Postoperative Pain Medication Market, by Region, 2023-2030 (US$ Mn)

TABLE 38 North America Postoperative Pain Medication Market, By Medication Type, 2017-2022 (US$ Mn)

TABLE 39 North America Postoperative Pain Medication Market, By Medication Type, 2023-2030 (US$ Mn)

TABLE 40 North America Postoperative Pain Medication Market, By Route of Administration, 2017-2022 (US$ Mn)

TABLE 41 North America Postoperative Pain Medication Market, By Route of Administration, 2023-2030 (US$ Mn)

TABLE 42 North America Postoperative Pain Medication Market, By Surgical Procedure, 2017-2022 (US$ Mn)

TABLE 43 North America Postoperative Pain Medication Market, By Surgical Procedure, 2023-2030 (US$ Mn)

TABLE 44 North AmericaPostoperative Pain Medication Market, By End-Users, By Region, 2017-2022 (US$ Mn)

TABLE 45 North AmericaPostoperative Pain Medication Market, By End-Users, By Region, 2023-2030 (US$ Mn)

TABLE 46 North AmericaPostoperative Pain Medication Market, by Patient Profile, 2017-2022 (US$ Mn)

TABLE 47 North AmericaPostoperative Pain Medication Market, by Patient Profile, 2023-2030 (US$ Mn)

TABLE 48 North America Postoperative Pain Medication Market, by Country, 2017-2022 (US$ Mn)

TABLE 49 North America Postoperative Pain Medication Market, by Country, 2023-2030 (US$ Mn)

TABLE 50 United States Postoperative Pain Medication Market, By Medication Type, 2017-2022 (US$ Mn)

TABLE 51 United States Postoperative Pain Medication Market, By Medication Type, 2023-2030 (US$ Mn)

TABLE 52 United States Postoperative Pain Medication Market, By Route of Administration, 2017-2022 (US$ Mn)

TABLE 53 United States Postoperative Pain Medication Market, By Route of Administration, 2023-2030 (US$ Mn)

TABLE 54 United States Postoperative Pain Medication Market, By Surgical Procedure, 2017-2022 (US$ Mn)

TABLE 55 United States Postoperative Pain Medication Market, By Surgical Procedure, 2023-2030 (US$ Mn)

TABLE 56 United StatesPostoperative Pain Medication Market, By End-Users, By Region, 2017-2022 (US$ Mn)

TABLE 57 United StatesPostoperative Pain Medication Market, By End-Users, By Region, 2023-2030 (US$ Mn)

TABLE 58 United StatesPostoperative Pain Medication Market, by Patient Profile, 2017-2022 (US$ Mn)

TABLE 59 United StatesPostoperative Pain Medication Market, by Patient Profile, 2023-2030 (US$ Mn)

TABLE 60 Canada Postoperative Pain Medication Market, By Medication Type, 2017-2022 (US$ Mn)

TABLE 61 Canada Postoperative Pain Medication Market, By Medication Type, 2023-2030 (US$ Mn)

TABLE 62 Canada Postoperative Pain Medication Market, By Route of Administration, 2017-2022 (US$ Mn)

TABLE 63 Canada Postoperative Pain Medication Market, By Route of Administration, 2023-2030 (US$ Mn)

TABLE 64 Canada Postoperative Pain Medication Market, By Surgical Procedure, 2017-2022 (US$ Mn)

TABLE 65 Canada Postoperative Pain Medication Market, By Surgical Procedure, 2023-2030 (US$ Mn)

TABLE 66 CanadaPostoperative Pain Medication Market, By End-Users, By Region, 2017-2022 (US$ Mn)

TABLE 67 CanadaPostoperative Pain Medication Market, By End-Users, By Region, 2023-2030 (US$ Mn)

TABLE 68 CanadaPostoperative Pain Medication Market, by Patient Profile, 2017-2022 (US$ Mn)

TABLE 69 CanadaPostoperative Pain Medication Market, by Patient Profile, 2023-2030 (US$ Mn)

TABLE 70 Mexico Postoperative Pain Medication Market, By Medication Type, 2017-2022 (US$ Mn)

TABLE 71 Mexico Postoperative Pain Medication Market, By Medication Type, 2023-2030 (US$ Mn)

TABLE 72 Mexico Postoperative Pain Medication Market, By Route of Administration, 2017-2022 (US$ Mn)

TABLE 73 Mexico Postoperative Pain Medication Market, By Route of Administration, 2023-2030 (US$ Mn)

TABLE 74 Mexico Postoperative Pain Medication Market, By Surgical Procedure, 2017-2022 (US$ Mn)

TABLE 75 Mexico Postoperative Pain Medication Market, By Surgical Procedure, 2023-2030 (US$ Mn)

TABLE 76 MexicoPostoperative Pain Medication Market, By End-Users, By Region, 2017-2022 (US$ Mn)

TABLE 77 MexicoPostoperative Pain Medication Market, By End-Users, By Region, 2023-2030 (US$ Mn)

TABLE 78 MexicoPostoperative Pain Medication Market, by Patient Profile, 2017-2022 (US$ Mn)

TABLE 79 MexicoPostoperative Pain Medication Market, by Patient Profile, 2023-2030 (US$ Mn)

TABLE 80 Europe Postoperative Pain Medication Market, By Medication Type, 2017-2022 (US$ Mn)

TABLE 81 Europe Postoperative Pain Medication Market, By Medication Type, 2023-2030 (US$ Mn)

TABLE 82 Europe Postoperative Pain Medication Market, By Route of Administration, 2017-2022 (US$ Mn)

TABLE 83 Europe Postoperative Pain Medication Market, By Route of Administration, 2023-2030 (US$ Mn)

TABLE 84 Europe Postoperative Pain Medication Market, By Surgical Procedure, 2017-2022 (US$ Mn)

TABLE 85 Europe Postoperative Pain Medication Market, By Surgical Procedure, 2023-2030 (US$ Mn)

TABLE 86 EuropePostoperative Pain Medication Market, By End-Users, By Region, 2017-2022 (US$ Mn)

TABLE 87 EuropePostoperative Pain Medication Market, By End-Users, By Region, 2023-2030 (US$ Mn)

TABLE 88 EuropePostoperative Pain Medication Market, by Patient Profile, 2017-2022 (US$ Mn)

TABLE 89 EuropePostoperative Pain Medication Market, by Patient Profile, 2023-2030 (US$ Mn)

TABLE 90 Europe Postoperative Pain Medication Market, by Country, 2017-2022 (US$ Mn)

TABLE 91 Europe Postoperative Pain Medication Market, by Country, 2023-2030 (US$ Mn)

TABLE 92 Germany Postoperative Pain Medication Market, By Medication Type, 2017-2022 (US$ Mn)

TABLE 93 Germany Postoperative Pain Medication Market, By Medication Type, 2023-2030 (US$ Mn)

TABLE 94 Germany Postoperative Pain Medication Market, By Route of Administration, 2017-2022 (US$ Mn)

TABLE 95 Germany Postoperative Pain Medication Market, By Route of Administration, 2023-2030 (US$ Mn)

TABLE 96 Germany Postoperative Pain Medication Market, By Surgical Procedure, 2017-2022 (US$ Mn)

TABLE 97 Germany Postoperative Pain Medication Market, By Surgical Procedure, 2023-2030 (US$ Mn)

TABLE 98 GermanyPostoperative Pain Medication Market, By End-Users, By Region, 2017-2022 (US$ Mn)

TABLE 99 GermanyPostoperative Pain Medication Market, By End-Users, By Region, 2023-2030 (US$ Mn)

TABLE 100 GermanyPostoperative Pain Medication Market, by Patient Profile, 2017-2022 (US$ Mn)

TABLE 101 GermanyPostoperative Pain Medication Market, by Patient Profile, 2023-2030 (US$ Mn)

TABLE 102 France Postoperative Pain Medication Market, By Medication Type, 2017-2022 (US$ Mn)

TABLE 103 France Postoperative Pain Medication Market, By Medication Type, 2023-2030 (US$ Mn)

TABLE 104 France Postoperative Pain Medication Market, By Route of Administration, 2017-2022 (US$ Mn)

TABLE 105 France Postoperative Pain Medication Market, By Route of Administration, 2023-2030 (US$ Mn)

TABLE 106 France Postoperative Pain Medication Market, By Surgical Procedure, 2017-2022 (US$ Mn)

TABLE 107 France Postoperative Pain Medication Market, By Surgical Procedure, 2023-2030 (US$ Mn)

TABLE 108 FrancePostoperative Pain Medication Market, By End-Users, By Region, 2017-2022 (US$ Mn)

TABLE 109 FrancePostoperative Pain Medication Market, By End-Users, By Region, 2023-2030 (US$ Mn)

TABLE 110 FrancePostoperative Pain Medication Market, by Patient Profile, 2017-2022 (US$ Mn)

TABLE 111 FrancePostoperative Pain Medication Market, by Patient Profile, 2023-2030 (US$ Mn)

TABLE 112 United Kingdom Postoperative Pain Medication Market, By Medication Type, 2017-2022 (US$ Mn)

TABLE 113 United Kingdom Postoperative Pain Medication Market, By Medication Type, 2023-2030 (US$ Mn)

TABLE 114 United Kingdom Postoperative Pain Medication Market, By Route of Administration, 2017-2022 (US$ Mn)

TABLE 115 United Kingdom Postoperative Pain Medication Market, By Route of Administration, 2023-2030 (US$ Mn)

TABLE 116 United Kingdom Postoperative Pain Medication Market, By Surgical Procedure, 2017-2022 (US$ Mn)

TABLE 117 United Kingdom Postoperative Pain Medication Market, By Surgical Procedure, 2023-2030 (US$ Mn)

TABLE 118 United KingdomPostoperative Pain Medication Market, By End-Users, By Region, 2017-2022 (US$ Mn)

TABLE 119 United KingdomPostoperative Pain Medication Market, By End-Users, By Region, 2023-2030 (US$ Mn)

TABLE 120 United KingdomPostoperative Pain Medication Market, by Patient Profile, 2017-2022 (US$ Mn)

TABLE 121 United KingdomPostoperative Pain Medication Market, by Patient Profile, 2023-2030 (US$ Mn)

TABLE 122 Italy Postoperative Pain Medication Market, By Medication Type, 2017-2022 (US$ Mn)

TABLE 123 Italy Postoperative Pain Medication Market, By Medication Type, 2023-2030 (US$ Mn)

TABLE 124 Italy Postoperative Pain Medication Market, By Route of Administration, 2017-2022 (US$ Mn)

TABLE 125 Italy Postoperative Pain Medication Market, By Route of Administration, 2023-2030 (US$ Mn)

TABLE 126 Italy Postoperative Pain Medication Market, By Surgical Procedure, 2017-2022 (US$ Mn)

TABLE 127 Italy Postoperative Pain Medication Market, By Surgical Procedure, 2023-2030 (US$ Mn)

TABLE 128 ItalyPostoperative Pain Medication Market, By End-Users, By Region, 2017-2022 (US$ Mn)

TABLE 129 ItalyPostoperative Pain Medication Market, By End-Users, By Region, 2023-2030 (US$ Mn)

TABLE 130 ItalyPostoperative Pain Medication Market, by Patient Profile, 2017-2022 (US$ Mn)

TABLE 131 ItalyPostoperative Pain Medication Market, by Patient Profile, 2023-2030 (US$ Mn)

TABLE 132 Spain Postoperative Pain Medication Market, By Medication Type, 2017-2022 (US$ Mn)

TABLE 133 Spain Postoperative Pain Medication Market, By Medication Type, 2023-2030 (US$ Mn)

TABLE 134 Spain Postoperative Pain Medication Market, By Route of Administration, 2017-2022 (US$ Mn)

TABLE 135 Spain Postoperative Pain Medication Market, By Route of Administration, 2023-2030 (US$ Mn)

TABLE 136 Spain Postoperative Pain Medication Market, By Surgical Procedure, 2017-2022 (US$ Mn)

TABLE 137 Spain Postoperative Pain Medication Market, By Surgical Procedure, 2023-2030 (US$ Mn)

TABLE 138 SpainPostoperative Pain Medication Market, By End-Users, By Region, 2017-2022 (US$ Mn)

TABLE 139 SpainPostoperative Pain Medication Market, By End-Users, By Region, 2023-2030 (US$ Mn)

TABLE 140 SpainPostoperative Pain Medication Market, by Patient Profile, 2017-2022 (US$ Mn)

TABLE 141 SpainPostoperative Pain Medication Market, by Patient Profile, 2023-2030 (US$ Mn)

TABLE 142 BeneluxPostoperative Pain Medication Market, By Medication Type, 2017-2022 (US$ Mn)

TABLE 143 BeneluxPostoperative Pain Medication Market, By Medication Type, 2023-2030 (US$ Mn)

TABLE 144 BeneluxPostoperative Pain Medication Market, By Route of Administration, 2017-2022 (US$ Mn)

TABLE 145 BeneluxPostoperative Pain Medication Market, By Route of Administration, 2023-2030 (US$ Mn)

TABLE 146 BeneluxPostoperative Pain Medication Market, By Surgical Procedure, 2017-2022 (US$ Mn)

TABLE 147 BeneluxPostoperative Pain Medication Market, By Surgical Procedure, 2023-2030 (US$ Mn)

TABLE 148 BeneluxPostoperative Pain Medication Market, By End-Users, By Region, 2017-2022 (US$ Mn)

TABLE 149 BeneluxPostoperative Pain Medication Market, By End-Users, By Region, 2023-2030 (US$ Mn)

TABLE 150 BeneluxPostoperative Pain Medication Market, by Patient Profile, 2017-2022 (US$ Mn)

TABLE 151 BeneluxPostoperative Pain Medication Market, by Patient Profile, 2023-2030 (US$ Mn)

TABLE 152 RussiaPostoperative Pain Medication Market, By Medication Type, 2017-2022 (US$ Mn)

TABLE 153 RussiaPostoperative Pain Medication Market, By Medication Type, 2023-2030 (US$ Mn)

TABLE 154 RussiaPostoperative Pain Medication Market, By Route of Administration, 2017-2022 (US$ Mn)

TABLE 155 RussiaPostoperative Pain Medication Market, By Route of Administration, 2023-2030 (US$ Mn)

TABLE 156 RussiaPostoperative Pain Medication Market, By Surgical Procedure, 2017-2022 (US$ Mn)

TABLE 157 RussiaPostoperative Pain Medication Market, By Surgical Procedure, 2023-2030 (US$ Mn)

TABLE 158 RussiaPostoperative Pain Medication Market, By End-Users, By Region, 2017-2022 (US$ Mn)

TABLE 159 RussiaPostoperative Pain Medication Market, By End-Users, By Region, 2023-2030 (US$ Mn)

TABLE 160 RussiaPostoperative Pain Medication Market, by Patient Profile, 2017-2022 (US$ Mn)

TABLE 161 RussiaPostoperative Pain Medication Market, by Patient Profile, 2023-2030 (US$ Mn)

TABLE 162 Rest of Europe Postoperative Pain Medication Market, By Medication Type, 2017-2022 (US$ Mn)

TABLE 163 Rest of Europe Postoperative Pain Medication Market, By Medication Type, 2023-2030 (US$ Mn)

TABLE 164 Rest of Europe Postoperative Pain Medication Market, By Route of Administration, 2017-2022 (US$ Mn)

TABLE 165 Rest of Europe Postoperative Pain Medication Market, By Route of Administration, 2023-2030 (US$ Mn)

TABLE 166 Rest of Europe Postoperative Pain Medication Market, By Surgical Procedure, 2017-2022 (US$ Mn)

TABLE 167 Rest of Europe Postoperative Pain Medication Market, By Surgical Procedure, 2023-2030 (US$ Mn)

TABLE 168 Rest of EuropePostoperative Pain Medication Market, By End-Users, By Region, 2017-2022 (US$ Mn)

TABLE 169 Rest of EuropePostoperative Pain Medication Market, By End-Users, By Region, 2023-2030 (US$ Mn)

TABLE 170 Rest of EuropePostoperative Pain Medication Market, by Patient Profile, 2017-2022 (US$ Mn)

TABLE 171 Rest of EuropePostoperative Pain Medication Market, by Patient Profile, 2023-2030 (US$ Mn)

TABLE 172 Asia Pacific Postoperative Pain Medication Market, By Medication Type, 2017-2022 (US$ Mn)

TABLE 173 Asia Pacific Postoperative Pain Medication Market, By Medication Type, 2023-2030 (US$ Mn)

TABLE 174 Asia Pacific Postoperative Pain Medication Market, By Route of Administration, 2017-2022 (US$ Mn)

TABLE 175 Asia Pacific Postoperative Pain Medication Market, By Route of Administration, 2023-2030 (US$ Mn)

TABLE 176 Asia Pacific Postoperative Pain Medication Market, By Surgical Procedure, 2017-2022 (US$ Mn)

TABLE 177 Asia Pacific Postoperative Pain Medication Market, By Surgical Procedure, 2023-2030 (US$ Mn)

TABLE 178 Asia PacificPostoperative Pain Medication Market, By End-Users, By Region, 2017-2022 (US$ Mn)

TABLE 179 Asia PacificPostoperative Pain Medication Market, By End-Users, By Region, 2023-2030 (US$ Mn)

TABLE 180 Asia PacificPostoperative Pain Medication Market, by Patient Profile, 2017-2022 (US$ Mn)

TABLE 181 Asia PacificPostoperative Pain Medication Market, by Patient Profile, 2023-2030 (US$ Mn)

TABLE 182 China Postoperative Pain Medication Market, By Medication Type, 2017-2022 (US$ Mn)

TABLE 183 China Postoperative Pain Medication Market, By Medication Type, 2023-2030 (US$ Mn)

TABLE 184 China Postoperative Pain Medication Market, By Route of Administration, 2017-2022 (US$ Mn)

TABLE 185 China Postoperative Pain Medication Market, By Route of Administration, 2023-2030 (US$ Mn)

TABLE 186 China Postoperative Pain Medication Market, By Surgical Procedure, 2017-2022 (US$ Mn)

TABLE 187 China Postoperative Pain Medication Market, By Surgical Procedure, 2023-2030 (US$ Mn)

TABLE 188 ChinaPostoperative Pain Medication Market, By End-Users, By Region, 2017-2022 (US$ Mn)

TABLE 189 ChinaPostoperative Pain Medication Market, By End-Users, By Region, 2023-2030 (US$ Mn)

TABLE 190 ChinaPostoperative Pain Medication Market, by Patient Profile, 2017-2022 (US$ Mn)

TABLE 191 ChinaPostoperative Pain Medication Market, by Patient Profile, 2023-2030 (US$ Mn)

TABLE 192 Japan Postoperative Pain Medication Market, By Medication Type, 2017-2022 (US$ Mn)

TABLE 193 Japan Postoperative Pain Medication Market, By Medication Type, 2023-2030 (US$ Mn)

TABLE 194 Japan Postoperative Pain Medication Market, By Route of Administration, 2017-2022 (US$ Mn)

TABLE 195 Japan Postoperative Pain Medication Market, By Route of Administration, 2023-2030 (US$ Mn)

TABLE 196 Japan Postoperative Pain Medication Market, By Surgical Procedure, 2017-2022 (US$ Mn)

TABLE 197 Japan Postoperative Pain Medication Market, By Surgical Procedure, 2023-2030 (US$ Mn)

TABLE 198 JapanPostoperative Pain Medication Market, By End-Users, By Region, 2017-2022 (US$ Mn)

TABLE 199 JapanPostoperative Pain Medication Market, By End-Users, By Region, 2023-2030 (US$ Mn)

TABLE 200 JapanPostoperative Pain Medication Market, by Patient Profile, 2017-2022 (US$ Mn)

TABLE 201 JapanPostoperative Pain Medication Market, by Patient Profile, 2023-2030 (US$ Mn)

TABLE 202 India Postoperative Pain Medication Market, By Medication Type, 2017-2022 (US$ Mn)

TABLE 203 India Postoperative Pain Medication Market, By Medication Type, 2023-2030 (US$ Mn)

TABLE 204 India Postoperative Pain Medication Market, By Route of Administration, 2017-2022 (US$ Mn)

TABLE 205 India Postoperative Pain Medication Market, By Route of Administration, 2023-2030 (US$ Mn)

TABLE 206 India Postoperative Pain Medication Market, By Surgical Procedure, 2017-2022 (US$ Mn)

TABLE 207 India Postoperative Pain Medication Market, By Surgical Procedure, 2023-2030 (US$ Mn)

TABLE 208 IndiaPostoperative Pain Medication Market, By End-Users, By Region, 2017-2022 (US$ Mn)

TABLE 209 IndiaPostoperative Pain Medication Market, By End-Users, By Region, 2023-2030 (US$ Mn)

TABLE 210 IndiaPostoperative Pain Medication Market, by Patient Profile, 2017-2022 (US$ Mn)

TABLE 211 IndiaPostoperative Pain Medication Market, by Patient Profile, 2023-2030 (US$ Mn)

TABLE 212 South Korea Postoperative Pain Medication Market, By Medication Type, 2017-2022 (US$ Mn)

TABLE 213 South Korea Postoperative Pain Medication Market, By Medication Type, 2023-2030 (US$ Mn)

TABLE 214 South Korea Postoperative Pain Medication Market, By Route of Administration, 2017-2022 (US$ Mn)

TABLE 215 South Korea Postoperative Pain Medication Market, By Route of Administration, 2023-2030 (US$ Mn)

TABLE 216 South Korea Postoperative Pain Medication Market, By Surgical Procedure, 2017-2022 (US$ Mn)

TABLE 217 South Korea Postoperative Pain Medication Market, By Surgical Procedure, 2023-2030 (US$ Mn)

TABLE 218 South KoreaPostoperative Pain Medication Market, By End-Users, By Region, 2017-2022 (US$ Mn)

TABLE 219 South KoreaPostoperative Pain Medication Market, By End-Users, By Region, 2023-2030 (US$ Mn)

TABLE 220 South KoreaPostoperative Pain Medication Market, by Patient Profile, 2017-2022 (US$ Mn)

TABLE 221 South KoreaPostoperative Pain Medication Market, by Patient Profile, 2023-2030 (US$ Mn)

TABLE 222 South-East Asia Postoperative Pain Medication Market, By Medication Type, 2017-2022 (US$ Mn)

TABLE 223 South-East Asia Postoperative Pain Medication Market, By Medication Type, 2023-2030 (US$ Mn)

TABLE 224 South-East Asia Postoperative Pain Medication Market, By Route of Administration, 2017-2022 (US$ Mn)

TABLE 225 South-East Asia Postoperative Pain Medication Market, By Route of Administration, 2023-2030 (US$ Mn)

TABLE 226 South-East Asia Postoperative Pain Medication Market, By Surgical Procedure, 2017-2022 (US$ Mn)

TABLE 227 South-East Asia Postoperative Pain Medication Market, By Surgical Procedure, 2023-2030 (US$ Mn)

TABLE 228 South-East AsiaPostoperative Pain Medication Market, By End-Users, By Region, 2017-2022 (US$ Mn)

TABLE 229 South-East AsiaPostoperative Pain Medication Market, By End-Users, By Region, 2023-2030 (US$ Mn)

TABLE 230 South-East AsiaPostoperative Pain Medication Market, by Patient Profile, 2017-2022 (US$ Mn)

TABLE 231 South-East AsiaPostoperative Pain Medication Market, by Patient Profile, 2023-2030 (US$ Mn)

TABLE 232 Rest of Asia Pacific Postoperative Pain Medication Market, By Medication Type, 2017-2022 (US$ Mn)

TABLE 233 Rest of Asia Pacific Postoperative Pain Medication Market, By Medication Type, 2023-2030 (US$ Mn)

TABLE 234 Rest of Asia Pacific Postoperative Pain Medication Market, By Route of Administration, 2017-2022 (US$ Mn)

TABLE 235 Rest of Asia Pacific Postoperative Pain Medication Market, By Route of Administration, 2023-2030 (US$ Mn)

TABLE 236 Rest of Asia Pacific Postoperative Pain Medication Market, By Surgical Procedure, 2017-2022 (US$ Mn)

TABLE 237 Rest of Asia Pacific Postoperative Pain Medication Market, By Surgical Procedure, 2023-2030 (US$ Mn)

TABLE 238 Rest of Asia PacificPostoperative Pain Medication Market, By End-Users, By Region, 2017-2022 (US$ Mn)

TABLE 239 Rest of Asia PacificPostoperative Pain Medication Market, By End-Users, By Region, 2023-2030 (US$ Mn)

TABLE 240 Rest of Asia PacificPostoperative Pain Medication Market, by Patient Profile, 2017-2022 (US$ Mn)

TABLE 241 Rest of Asia PacificPostoperative Pain Medication Market, by Patient Profile, 2023-2030 (US$ Mn)

TABLE 242 Latin America Postoperative Pain Medication Market, By Medication Type, 2017-2022 (US$ Mn)

TABLE 243 Latin America Postoperative Pain Medication Market, By Medication Type, 2023-2030 (US$ Mn)

TABLE 244 Latin America Postoperative Pain Medication Market, By Route of Administration, 2017-2022 (US$ Mn)

TABLE 245 Latin America Postoperative Pain Medication Market, By Route of Administration, 2023-2030 (US$ Mn)

TABLE 246 Latin America Postoperative Pain Medication Market, By Surgical Procedure, 2017-2022 (US$ Mn)

TABLE 247 Latin America Postoperative Pain Medication Market, By Surgical Procedure, 2023-2030 (US$ Mn)

TABLE 248 Latin AmericaPostoperative Pain Medication Market, By End-Users, By Region, 2017-2022 (US$ Mn)

TABLE 249 Latin AmericaPostoperative Pain Medication Market, By End-Users, By Region, 2023-2030 (US$ Mn)

TABLE 250 Latin AmericaPostoperative Pain Medication Market, by Patient Profile, 2017-2022 (US$ Mn)

TABLE 251 Latin AmericaPostoperative Pain Medication Market, by Patient Profile, 2023-2030 (US$ Mn)

TABLE 252 Brazil Postoperative Pain Medication Market, By Medication Type, 2017-2022 (US$ Mn)

TABLE 253 Brazil Postoperative Pain Medication Market, By Medication Type, 2023-2030 (US$ Mn)

TABLE 254 Brazil Postoperative Pain Medication Market, By Route of Administration, 2017-2022 (US$ Mn)

TABLE 255 Brazil Postoperative Pain Medication Market, By Route of Administration, 2023-2030 (US$ Mn)

TABLE 256 Brazil Postoperative Pain Medication Market, By Surgical Procedure, 2017-2022 (US$ Mn)

TABLE 257 Brazil Postoperative Pain Medication Market, By Surgical Procedure, 2023-2030 (US$ Mn)

TABLE 258 BrazilPostoperative Pain Medication Market, By End-Users, By Region, 2017-2022 (US$ Mn)

TABLE 259 BrazilPostoperative Pain Medication Market, By End-Users, By Region, 2023-2030 (US$ Mn)

TABLE 260 BrazilPostoperative Pain Medication Market, by Patient Profile, 2017-2022 (US$ Mn)

TABLE 261 BrazilPostoperative Pain Medication Market, by Patient Profile, 2023-2030 (US$ Mn)

TABLE 262 Argentina Postoperative Pain Medication Market, By Medication Type, 2017-2022 (US$ Mn)

TABLE 263 Argentina Postoperative Pain Medication Market, By Medication Type, 2023-2030 (US$ Mn)

TABLE 264 Argentina Postoperative Pain Medication Market, By Route of Administration, 2017-2022 (US$ Mn)

TABLE 265 Argentina Postoperative Pain Medication Market, By Route of Administration, 2023-2030 (US$ Mn)

TABLE 266 Argentina Postoperative Pain Medication Market, By Surgical Procedure, 2017-2022 (US$ Mn)

TABLE 267 Argentina Postoperative Pain Medication Market, By Surgical Procedure, 2023-2030 (US$ Mn)

TABLE 268 ArgentinaPostoperative Pain Medication Market, By End-Users, By Region, 2017-2022 (US$ Mn)

TABLE 269 ArgentinaPostoperative Pain Medication Market, By End-Users, By Region, 2023-2030 (US$ Mn)

TABLE 270 ArgentinaPostoperative Pain Medication Market, by Patient Profile, 2017-2022 (US$ Mn)

TABLE 271 ArgentinaPostoperative Pain Medication Market, by Patient Profile, 2023-2030 (US$ Mn)

TABLE 272 Rest of Latin America Postoperative Pain Medication Market, By Medication Type, 2017-2022 (US$ Mn)

TABLE 273 Rest of Latin America Postoperative Pain Medication Market, By Medication Type, 2023-2030 (US$ Mn)

TABLE 274 Rest of Latin America Postoperative Pain Medication Market, By Route of Administration, 2017-2022 (US$ Mn)

TABLE 275 Rest of Latin America Postoperative Pain Medication Market, By Route of Administration, 2023-2030 (US$ Mn)

TABLE 276 Rest of Latin America Postoperative Pain Medication Market, By Surgical Procedure, 2017-2022 (US$ Mn)

TABLE 277 Rest of Latin America Postoperative Pain Medication Market, By Surgical Procedure, 2023-2030 (US$ Mn)

TABLE 278 Rest of Latin AmericaPostoperative Pain Medication Market, By End-Users, By Region, 2017-2022 (US$ Mn)

TABLE 279 Rest of Latin AmericaPostoperative Pain Medication Market, By End-Users, By Region, 2023-2030 (US$ Mn)

TABLE 280 Rest of Latin AmericaPostoperative Pain Medication Market, by Patient Profile, 2017-2022 (US$ Mn)

TABLE 281 Rest of Latin AmericaPostoperative Pain Medication Market, by Patient Profile, 2023-2030 (US$ Mn)

TABLE 282 Middle EastPostoperative Pain Medication Market, By Medication Type, 2017-2022 (US$ Mn)

TABLE 283 Middle EastPostoperative Pain Medication Market, By Medication Type, 2023-2030 (US$ Mn)

TABLE 284 Middle EastPostoperative Pain Medication Market, By Route of Administration, 2017-2022 (US$ Mn)

TABLE 285 Middle EastPostoperative Pain Medication Market, By Route of Administration, 2023-2030 (US$ Mn)

TABLE 286 Middle EastPostoperative Pain Medication Market, By Surgical Procedure, 2017-2022 (US$ Mn)

TABLE 287 Middle EastPostoperative Pain Medication Market, By Surgical Procedure, 2023-2030 (US$ Mn)

TABLE 288 Middle EastPostoperative Pain Medication Market, By End-Users, By Region, 2017-2022 (US$ Mn)

TABLE 289 Middle EastPostoperative Pain Medication Market, By End-Users, By Region, 2023-2030 (US$ Mn)

TABLE 290 Middle EastPostoperative Pain Medication Market, by Patient Profile, 2017-2022 (US$ Mn)

TABLE 291 Middle EastPostoperative Pain Medication Market, by Patient Profile, 2023-2030 (US$ Mn)

TABLE 292 UAEPostoperative Pain Medication Market, By Medication Type, 2017-2022 (US$ Mn)

TABLE 293 UAEPostoperative Pain Medication Market, By Medication Type, 2023-2030 (US$ Mn)

TABLE 294 UAEPostoperative Pain Medication Market, By Route of Administration, 2017-2022 (US$ Mn)

TABLE 295 UAEPostoperative Pain Medication Market, By Route of Administration, 2023-2030 (US$ Mn)

TABLE 296 UAEPostoperative Pain Medication Market, By Surgical Procedure, 2017-2022 (US$ Mn)

TABLE 297 UAEPostoperative Pain Medication Market, By Surgical Procedure, 2023-2030 (US$ Mn)

TABLE 298 UAEPostoperative Pain Medication Market, By End-Users, By Region, 2017-2022 (US$ Mn)

TABLE 299 UAEPostoperative Pain Medication Market, By End-Users, By Region, 2023-2030 (US$ Mn)

TABLE 300 UAEPostoperative Pain Medication Market, by Patient Profile, 2017-2022 (US$ Mn)

TABLE 301 UAEPostoperative Pain Medication Market, by Patient Profile, 2023-2030 (US$ Mn)

TABLE 302 Saudi ArabiaPostoperative Pain Medication Market, By Medication Type, 2017-2022 (US$ Mn)

TABLE 303 Saudi ArabiaPostoperative Pain Medication Market, By Medication Type, 2023-2030 (US$ Mn)

TABLE 304 Saudi ArabiaPostoperative Pain Medication Market, By Route of Administration, 2017-2022 (US$ Mn)

TABLE 305 Saudi ArabiaPostoperative Pain Medication Market, By Route of Administration, 2023-2030 (US$ Mn)

TABLE 306 Saudi ArabiaPostoperative Pain Medication Market, By Surgical Procedure, 2017-2022 (US$ Mn)

TABLE 307 Saudi ArabiaPostoperative Pain Medication Market, By Surgical Procedure, 2023-2030 (US$ Mn)

TABLE 308 Saudi ArabiaPostoperative Pain Medication Market, By End-Users, By Region, 2017-2022 (US$ Mn)

TABLE 309 Saudi ArabiaPostoperative Pain Medication Market, By End-Users, By Region, 2023-2030 (US$ Mn)

TABLE 310 Saudi ArabiaPostoperative Pain Medication Market, by Patient Profile, 2017-2022 (US$ Mn)

TABLE 311 Saudi ArabiaPostoperative Pain Medication Market, by Patient Profile, 2023-2030 (US$ Mn)

TABLE 312 Rest of Middle EastPostoperative Pain Medication Market, By Medication Type, 2017-2022 (US$ Mn)

TABLE 313 Rest of Middle EastPostoperative Pain Medication Market, By Medication Type, 2023-2030 (US$ Mn)

TABLE 314 Rest of Middle EastPostoperative Pain Medication Market, By Route of Administration, 2017-2022 (US$ Mn)

TABLE 315 Rest of Middle EastPostoperative Pain Medication Market, By Route of Administration, 2023-2030 (US$ Mn)

TABLE 316 Rest of Middle EastPostoperative Pain Medication Market, By Surgical Procedure, 2017-2022 (US$ Mn)

TABLE 317 Rest of Middle EastPostoperative Pain Medication Market, By Surgical Procedure, 2023-2030 (US$ Mn)

TABLE 318 Rest of Middle EastPostoperative Pain Medication Market, By End-Users, By Region, 2017-2022 (US$ Mn)

TABLE 319 Rest of Middle EastPostoperative Pain Medication Market, By End-Users, By Region, 2023-2030 (US$ Mn)

TABLE 320 Rest of Middle EastPostoperative Pain Medication Market, by Patient Profile, 2017-2022 (US$ Mn)

TABLE 321 Rest of Middle EastPostoperative Pain Medication Market, by Patient Profile, 2023-2030 (US$ Mn)

TABLE 322 AfricaPostoperative Pain Medication Market, By Medication Type, 2017-2022 (US$ Mn)

TABLE 323 AfricaPostoperative Pain Medication Market, By Medication Type, 2023-2030 (US$ Mn)

TABLE 324 AfricaPostoperative Pain Medication Market, By Route of Administration, 2017-2022 (US$ Mn)

TABLE 325 AfricaPostoperative Pain Medication Market, By Route of Administration, 2023-2030 (US$ Mn)

TABLE 326 AfricaPostoperative Pain Medication Market, By Surgical Procedure, 2017-2022 (US$ Mn)

TABLE 327 AfricaPostoperative Pain Medication Market, By Surgical Procedure, 2023-2030 (US$ Mn)

TABLE 328 AfricaPostoperative Pain Medication Market, By End-Users, By Region, 2017-2022 (US$ Mn)

TABLE 329 AfricaPostoperative Pain Medication Market, By End-Users, By Region, 2023-2030 (US$ Mn)

TABLE 330 AfricaPostoperative Pain Medication Market, by Patient Profile, 2017-2022 (US$ Mn)

TABLE 331 AfricaPostoperative Pain Medication Market, by Patient Profile, 2023-2030 (US$ Mn)

TABLE 332 South AfricaPostoperative Pain Medication Market, By Medication Type, 2017-2022 (US$ Mn)

TABLE 333 South AfricaPostoperative Pain Medication Market, By Medication Type, 2023-2030 (US$ Mn)

TABLE 334 South AfricaPostoperative Pain Medication Market, By Route of Administration, 2017-2022 (US$ Mn)

TABLE 335 South AfricaPostoperative Pain Medication Market, By Route of Administration, 2023-2030 (US$ Mn)

TABLE 336 South AfricaPostoperative Pain Medication Market, By Surgical Procedure, 2017-2022 (US$ Mn)

TABLE 337 South AfricaPostoperative Pain Medication Market, By Surgical Procedure, 2023-2030 (US$ Mn)

TABLE 338 South AfricaPostoperative Pain Medication Market, By End-Users, By Region, 2017-2022 (US$ Mn)

TABLE 339 South AfricaPostoperative Pain Medication Market, By End-Users, By Region, 2023-2030 (US$ Mn)

TABLE 340 South AfricaPostoperative Pain Medication Market, by Patient Profile, 2017-2022 (US$ Mn)

TABLE 341 South AfricaPostoperative Pain Medication Market, by Patient Profile, 2023-2030 (US$ Mn)

TABLE 342 EgyptPostoperative Pain Medication Market, By Medication Type, 2017-2022 (US$ Mn)

TABLE 343 EgyptPostoperative Pain Medication Market, By Medication Type, 2023-2030 (US$ Mn)

TABLE 344 EgyptPostoperative Pain Medication Market, By Route of Administration, 2017-2022 (US$ Mn)

TABLE 345 EgyptPostoperative Pain Medication Market, By Route of Administration, 2023-2030 (US$ Mn)

TABLE 346 EgyptPostoperative Pain Medication Market, By Surgical Procedure, 2017-2022 (US$ Mn)

TABLE 347 EgyptPostoperative Pain Medication Market, By Surgical Procedure, 2023-2030 (US$ Mn)

TABLE 348 EgyptPostoperative Pain Medication Market, By End-Users, By Region, 2017-2022 (US$ Mn)

TABLE 349 EgyptPostoperative Pain Medication Market, By End-Users, By Region, 2023-2030 (US$ Mn)

TABLE 350 EgyptPostoperative Pain Medication Market, by Patient Profile, 2017-2022 (US$ Mn)

TABLE 351 EgyptPostoperative Pain Medication Market, by Patient Profile, 2023-2030 (US$ Mn)

TABLE 352 Rest of AfricaPostoperative Pain Medication Market, By Medication Type, 2017-2022 (US$ Mn)

TABLE 353 Rest of AfricaPostoperative Pain Medication Market, By Medication Type, 2023-2030 (US$ Mn)

TABLE 354 Rest of AfricaPostoperative Pain Medication Market, By Route of Administration, 2017-2022 (US$ Mn)

TABLE 355 Rest of AfricaPostoperative Pain Medication Market, By Route of Administration, 2023-2030 (US$ Mn)

TABLE 356 Rest of AfricaPostoperative Pain Medication Market, By Surgical Procedure, 2017-2022 (US$ Mn)

TABLE 357 Rest of AfricaPostoperative Pain Medication Market, By Surgical Procedure, 2023-2030 (US$ Mn)

TABLE 358 Rest of AfricaPostoperative Pain Medication Market, By End-Users, By Region, 2017-2022 (US$ Mn)

TABLE 359 Rest of AfricaPostoperative Pain Medication Market, By End-Users, By Region, 2023-2030 (US$ Mn)

TABLE 360 Rest of AfricaPostoperative Pain Medication Market, by Patient Profile, 2017-2022 (US$ Mn)

TABLE 361 Rest of AfricaPostoperative Pain Medication Market, by Patient Profile, 2023-2030 (US$ Mn)

Frequently Asked Questions

What is the current Surgical Procedure of the worldwide Postoperative Pain Medication Market?

In 2022, the global Postoperative Pain Medication Market is expected to be worth USD 32154.9million.

What is the predicted growth rate of the Postoperative Pain Medication Market between 2023 and 2030?

The Postoperative Pain Medication Market is estimated to increase at a CAGR of 5.80% between 2023 and 2030, reaching USD 50481.5Million in 2030.

Which segment has the most market share in Route of Administration?

In 2022, The oral category retains a dominant market share

Which Surgical Procedure segment governs the market demand for Postoperative Pain Medication?

Orthopedic surgery is a major player in the postoperative pain treatment sector.

Which Patient Profile segment is predicted to grow at the highest rate over the forecast period?

Pediatric patients have the highest compound annual growth rate (CAGR),

Which region is driving the Postoperative Pain Medication industry forward?

North America held a dominant market share of 35% in the year 2022.

Who are the major players in the global Postoperative Pain Medication Market?

The top players include AbbVie (Allergan), Heron Therapeutics, Cali Biosciences, Acadia Pharmaceuticals, Virpax Pharmaceuticals, GlaxoSmithKline Plc, Pacira Pharmaceuticals Inc

What are the major market drivers of the Postoperative Pain Medication industry?

The increasing number of surgical procedures worldwide, rising knowledge about the necessity of efficient pain management, and advancements in pharmaceutical formulations and drug delivery technologies are the primary market drivers.

What are the major market restraints of the Postoperative Pain Medication industry?

The primary problems confronting the postoperative pain management industry include the requirement for effective pain control while reducing side effects, the heterogeneity in individual pain experiences and reactions to therapy, and the necessity for continual monitoring and adjustment of pain management strategies.

What are the major market opportunities of the Postoperative Pain Medication industry?

The deployment of multimodal techniques, integration of digital health technology for real-time monitoring, and collaboration between healthcare professionals and patients to establish tailored pain management regimens are the significant opportunities in the postoperative pain medication market. These opportunities aim to increase pain treatment, patient satisfaction, and postoperative recovery results.

U.S. 503b Compounding Pharmacies Market

Published:
Report ID: 15988

UAE Minimally Invasive Biopsy Techniques Market

Published:
Report ID: 38790

Saudi Arabia Minimally Invasive Biopsy Technique Market

Published:
Report ID: 38766

Lung Cancer Therapeutics Market

Published:
Report ID: 38769

Breast Cancer Market

Published:
Report ID: 38761

Positive Patient Identification (PPID) Market

Published:
Report ID: 10622

Inflation Devices Market

Published:
Report ID: 38697

Microbiology Culture Market

Published:
Report ID: 38672

Medical Processing Seals Market

Published:
Report ID: 38667

Egypt In-Vitro Fertilization (IVF) Market

Published:
Report ID: 38526

Middle East Lab Titration Devices Market

Published:
Report ID: 38542

Tattoo Needles Market

Published:
Report ID: 10912

Purchase Options

$2999
Delivery Format: Excel.
$4999
Designed for the individual purchaser.
$6999
Users located at a single corporate site or regional office.
$7999
Allowed for unlimited sharing globally within one company.
Smallform of Sample request

Have a question?

User Profile

Don’t settle for less – trust Mitul to help you find the best solution.

Report delivery within 24 to 48 hours

– Other Info –

What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –

Phone

+91 6232 49 3207


support

24/7 Research Support


sales@credenceresearch.com

– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN